Ranitid 150 mg (Tablet)
Unit Price: ৳ 3.00 (21 x 10: ৳ 630.00)
Strip Price: ৳ 30.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Opsonin pharma ltd |
| Also available as |
Title
- Ranitid 150mg Tablet
- Ranitid Syrup
- Ranitid Injection
Categories
- Gastric Medication
- Ulcer Treatment
- Reflux Management
- Acid Reducer
- H2-Receptor Antagonist
Description
- Competitively blocks histamine at H2-receptors
- Inhibits gastric acid secretion
- Dosage for duodenal and gastric ulcer
- Interacts with propantheline bromide
- Contraindicated in patients hypersensitive to Ranitidine
- Well-tolerated with uncommon side effects
- Crosses placenta during pregnancy
Color Options
- White
- Clear
Dosage Form
- Tablet
- Syrup
- IV Injection
- IV Infusion
Dosage Strengths
- 150mg
- 300mg
- 50mg
- 2-4 mg/kg
Usual Dosage
- 150 mg twice daily
- 300 mg once daily at night
- 300 mg at bedtime
Recommended Dosage for Children
- 2-4 mg/kg twice daily
- Maximum 300 mg daily
Pharmacology
- Does not affect pepsin secretion
- Does not affect serum gastrin
- Blocks histamine at H2-receptors of parietal cells
Mode of Administration
- Oral
- Intravenous
- Slow IV Injection
- Intermittent slow IV Infusion
- Continuous IV Infusion
- Intramuscular
Drug Interactions
- Propantheline bromide
- Coumarin anticoagulants
- Theophylline
- Diazepam
- Propranolol
- Ketoconazole
- Midazolam
- Glipizide
- Antacids
Contraindications
- Hypersensitivity to Ranitidine
Side Effects
- Altered bowel habit
- Dizziness
- Rash
- Tiredness
- Reversible confusional states
- Headache
- Decreased blood counts
- Muscle or joint pain
Pregnancy
- Crosses the placenta
- Should be used only if essential
Lactation
- Excreted in human breast milk
- Caution in nursing mothers
Precautions
- Reduced dosage for impaired renal function
- Reduced dosage for impaired hepatic function
Special Populations
- Use in elderly patients
Overdose Effects
- Specific action
- Symptomatic and supportive therapy
- Potential removal by haemodialysis
Therapeutic Class
- H2 receptor antagonist
Reconstitution
- Various dilution concentrations for IV administration
Storage Conditions
- Cool and dry place
- Protect from light
Special Indications
- Treatment of active duodenal ulcer
- Benign gastric ulcer
- Prevention of ulcer associated with non-steroidal anti-inflammatory agent
- Post operative stress ulcer
- Zollinger-Ellison Syndrome
- Gastroesophageal reflux disease (GERD)
- Gastro-intestinal haemorrhage from stress ulcer
- Recurrent haemorrhage in patients with bleeding peptic ulcer
- Before general anesthesia for patients at risk of acid aspiration
- Elderly patients
- Zollinger-Ellison syndrome or other hypersecretory conditions